Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Transp Health. 2016 Sep 13;3(4):426–439. doi: 10.1016/j.jth.2016.08.006

Appendix Table A.1.

Comparison of included cases (movers with complete data) and excluded cases (non-movers, movers with incomplete data) on baseline characteristics

Characteristics Included cases Excluded cases a

Movers with complete data (n=1,079) Non-movers (n=1,661) Movers with incomplete data (n=429)
Built environment exposure
Walkability index 20.14 (7.70) 19.73 (7.53) 20.26 (7.90)
Health outcomes
Physical activity from walking
    Participation (%) 75.72 76.27 76.47
    Exercise units 49.31 (50.59) 49.61 (51.10) 50.54 (51.86)
Body mass index, kg/m2 28.41 (6.50) 28.77 (6.81) 29.10 (7.39)*
Waist circumference, cm 88.79 (15.01) 89.09 (14.91) 90.63 (16.59)**
Systolic blood pressure, mmHg 112.24 (13.69) 112.94 (15.18) 114.20 (15.26)**
HOMA-IR (insulin resistance) 2.30 (1.81) 2.41 (2.14) 2.94 (3.49)***
Triglycerides, mg/dL 95.37 (57.22) 104.63 (96.72)*** 126.60 (139.34)***
LDL cholesterol, mg/dL 113.44 (33.90) 112.88 (30.71) 114.13 (34.80)
HDL cholesterol, mg/dL 51.29 (14.49) 50.83 (14.51) 49.54 (15.03)**
C-reactive protein, ug/mL 3.11 (5.06) 3.29 (5.87) 3.33 (5.01)
Atherogenic dyslipidemia (%) 9.27 11.56* 14.45***
Sociodemographic covariates
Age, in years 39.67 (3.68) 40.76 (3.45)*** 39.86 (3.69)
Female (%) 54.77 58.34* 55.94
White race/ethnicity (vs. black) (%) 49.12 60.14*** 51.52
More than high school (vs. less/equal) (%) 58.20 65.02*** 55.40
Income, in thousands of U.S. dollars 62.51 (38.86) 73.29 (37.77)*** 57.94 (37.71)**
Household size 3.04 (1.61) 3.26 (1.47)*** 3.03 (1.60)
Currently married (%) 46.80 62.17*** 46.59
Currently working (%) 85.82 87.12 82.05*
Health covariates
Current smoker (%) 23.63 16.13*** 26.81
Health problems interfere with PA (%) 14.55 16.93* 16.86
On medication(s) for hypertension (%) 6.58 7.71 7.71
On medication(s) for cholesterol (%) 1.11 2.65** 2.56**

LDL = low-density lipoprotein, HDL = high-density lipoprotein, PA = physical activity, HOMA-IR = homeostasis model assessment of insulin resistance

*

significant at 90% confidence

**

significant at 95% confidence

***

significant at 99% confidence

a

significance levels for group differences (relative to included cases) based on p-value from ANOVA for continuous variables, χ2 test for categorical variables